ESR1 and cancer: Of note, the Danish study reported an association between the use of prolactin-increasing antipsychotics and estrogen-receptor-positive cancers, but no association for estrogen-receptor-negative cancers.26 This finding has not been replicated since, and such information was not available in the cancer registry used for the study reported here.